Program 40 mg Suspension for Injection for Cats
Program 40 mg Suspension for Injection for Cats
Authorised
- Lufenuron
Product identification
Medicine name:
Program 40 mg Suspension for Injection for Cats
Program, 40 mg suspensie voor injectie voor katten
Active substance:
- Lufenuron
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Lufenuron40.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53BC01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Available in:
-
Netherlands
Package description:
- cardboard box containing 10 syringes
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 9489
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0422/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Germany
-
Luxembourg
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2022
How useful was this page?:
